These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 15529607)

  • 1. The role of octreotide on renal function in patients with advanced cirrhosis.
    Fierbinţeanu-Braticevici C; Udeanu M; Usvat R; Andronescu D
    Rom J Intern Med; 2004; 42(1):173-81. PubMed ID: 15529607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide.
    Angeli P; Volpin R; Gerunda G; Craighero R; Roner P; Merenda R; Amodio P; Sticca A; Caregaro L; Maffei-Faccioli A; Gatta A
    Hepatology; 1999 Jun; 29(6):1690-7. PubMed ID: 10347109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of octreotide on central hemodynamics and systemic oxygen use in patients with viral cirrhosis.
    Lin HC; Hou MC; Lee WC; Huang YT; Lee FY; Chang FY; Tsai YT; Lee SD
    Am J Gastroenterol; 1999 Apr; 94(4):1012-7. PubMed ID: 10201475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapeutic effect of somatostatin analog octreotide on esophaged-gastric varices bleeding].
    Zhang AG; Wang JB; Zhao P; Jiao J; Wang G
    Zhonghua Gan Zang Bing Za Zhi; 2003 Mar; 11(3):152. PubMed ID: 12681061
    [No Abstract]   [Full Text] [Related]  

  • 5. Renal effects of treatment with diuretics, octreotide or both, in non-azotemic cirrhotic patients with ascites.
    Kalambokis G; Economou M; Fotopoulos A; Bokharhii JA; Katsaraki A; Tsianos EV
    Nephrol Dial Transplant; 2005 Aug; 20(8):1623-9. PubMed ID: 15886218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute hemodynamic effects of octreotide and terlipressin in patients with cirrhosis: a randomized comparison.
    Baik SK; Jeong PH; Ji SW; Yoo BS; Kim HS; Lee DK; Kwon SO; Kim YJ; Park JW; Chang SJ; Lee SS
    Am J Gastroenterol; 2005 Mar; 100(3):631-5. PubMed ID: 15743362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous subcutaneous octreotide in gastrointestinal cancer patients: pain control and beta-endorphin levels.
    Befon S; Mystakidou K; Lyra M; Tubanakis N; Vlahos L
    Anticancer Res; 2000; 20(5C):4039-46. PubMed ID: 11268498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Octreotide in the treatment of refractory ascites of cirrhosis.
    Leong RW; Jeffrey GP
    Scand J Gastroenterol; 2006 Jun; 41(6):763; author reply 764. PubMed ID: 16716981
    [No Abstract]   [Full Text] [Related]  

  • 9. A 3-month course of long-acting repeatable octreotide (sandostatin LAR) improves portal hypertension in patients with cirrhosis: a randomized controlled study.
    Spahr L; Giostra E; Frossard JL; Morard I; Mentha G; Hadengue A
    Am J Gastroenterol; 2007 Jul; 102(7):1397-405. PubMed ID: 17488248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beneficial haemodynamic and renal sodium handling effects of combined midodrine and octreotide treatment in a cirrhotic patient with large hepatic hydrothorax and mild ascites.
    Kalambokis G; Fotopoulos A; Economou M; Tsianos EV
    Nephrol Dial Transplant; 2005 Nov; 20(11):2583. PubMed ID: 16105868
    [No Abstract]   [Full Text] [Related]  

  • 11. Can octreotide be the first line treatment for chylothorax?
    Leelahanon S; Petlek W; Sontimuang W; Pochanart P; Tepakorn V; Ruangpeg S
    J Med Assoc Thai; 2003 Aug; 86 Suppl 3():S741-5. PubMed ID: 14700175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Octreotide bolus injection and azygos blood flow in patients with cirrhosis: is the effect really predictable?
    Spahr L; Giostra E; Mentha G; Hadengue A
    J Clin Gastroenterol; 2010 Oct; 44(9):e206-9. PubMed ID: 19996986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Local arterial vasoconstriction induced by octreotide in patients with cirrhosis.
    Chatila R; Ferayorni L; Gupta T; Groszmann RJ
    Hepatology; 2000 Mar; 31(3):572-6. PubMed ID: 10706544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of chronic treatment with octreotide versus octreotide plus midodrine on systemic hemodynamics and renal hemodynamics and function in nonazotemic cirrhotic patients with ascites.
    Kalambokis G; Economou M; Fotopoulos A; Al Bokharhii J; Pappas C; Katsaraki A; Tsianos EV
    Am J Gastroenterol; 2005 Apr; 100(4):879-85. PubMed ID: 15784036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Midodrine and octreotide in treatment of cirrhosis-related hemodynamic complications.
    Karwa R; Woodis CB
    Ann Pharmacother; 2009 Apr; 43(4):692-9. PubMed ID: 19299324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomised trial of octreotide for long term management of cirrhosis after variceal hemorrhage.
    Sheikh RA; Trudeau WL
    Gastrointest Endosc; 1998 Sep; 48(3):328-30. PubMed ID: 9744619
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of subcutaneous administration of octreotide on endogenous vasoactive systems and renal function in cirrhotic patients with ascites.
    Sàbat M; Guarner C; Soriano G; Bulbena O; Novella MT; Ortiz J; Ricart E; Villanueva C; Rosello J; Rodríguez J; Balanzó J
    Dig Dis Sci; 1998 Oct; 43(10):2184-9. PubMed ID: 9790452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effective made of octreotide intravenous administration for malignant gastrointestinal obstruction in terminal cancer patients].
    Tanimura K; Onda S; Mitsunobu M
    Gan To Kagaku Ryoho; 2010 Oct; 37(10):1991-3. PubMed ID: 20948271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatocellular carcinoma and octreotide: treatment results in prospectively assigned patients with advanced tumor and cirrhosis stage.
    Plentz RR; Tillmann HL; Kubicka S; Bleck JS; Gebel M; Manns MP; Rudolph KL
    J Gastroenterol Hepatol; 2005 Sep; 20(9):1422-8. PubMed ID: 16105131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Octreotide inhibits pancreatic exocrine secretion and prevents pancreatoenterostomy leakage.
    Nakatsuka A; Yamaguchi K; Chijiiwa K; Tanaka M
    Int Surg; 2000; 85(2):124-9. PubMed ID: 11071328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.